INVITAE, a genetic-testing company with backers including SoftBank Group and Cathie Wood’s Ark Investment Management, has filed for bankruptcy as the DNA testing industry struggles to regain investor ...

– Collaboration will simplify providers' and patients' access to discrete test results that can inform more precise, personalized medicine – SAN FRANCISCO, March 21, 2023 /PRNewswire/ -- Invitae (NVTA ...

Invitae Corporation (NYSE: NVTA), a genetic information company, has announced that it has more than doubled the size of its genetic testing platform to include more than 600 genes and will begin ...

Invitae, a medical genetic testing company, has filed for Chapter 11 bankruptcy and intends to continue the case without disrupting operations using cash on hand and while seeking to sell its business ...

Invitae Corporation (NYSE:NVTA), backed by SoftBank Group (OTC:SFTBY) (OTC:SFTBF), is reportedly on the brink of filing for bankruptcy in the coming weeks. The San Francisco-based medical genetics ...

Invitae, a leading medical genetics company, announced the availability of Detect Hereditary Pancreatic Cancer, a testing programme that offers no-charge genetic testing and counselling to patients ...

SAN FRANCISCO, March 15, 2023 /PRNewswire/ -- Invitae (NVTA) (NYSE: NVTA), a leading medical genetics company, today announced seven studies, including one oral presentation and six posters, to be ...

BURLINGTON, N.C. - Labcorp (NYSE: LH), a prominent provider of laboratory services, announced today the acquisition of select assets from Invitae (OTC:NVTAQ), a medical genetics company. This ...

They don’t have any preferred status over Invitae at any network. In the end, as with much other new in the area, we are encouraged in interest and any additional visibility that is brought to bear on ...